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Abstract 
Bacillus thuringiensis (Bt) produces insecticidal proteins that have been used worldwide in the control of insect‑pests 
in crops and vectors of human diseases. However, different insect species are poorly controlled by the available Bt 
toxins or have evolved resistance to these toxins. Evolution of Bt toxicity could provide novel toxins to control insect 
pests. To this aim, efficient display systems to select toxins with increased binding to insect membranes or midgut 
proteins involved in toxicity are likely to be helpful. Here we describe two display systems, phage display and ribo‑
some display, that allow the efficient display of two non‑structurally related Bt toxins, Cry1Ac and Cyt1Aa. Improved 
display of Cry1Ac and Cyt1Aa on M13 phages was achieved by changing the commonly used peptide leader 
sequence of the coat pIII‑fusion protein, that relies on the Sec translocation pathway, for a peptide leader sequence 
that relies on the signal recognition particle pathway (SRP) and by using a modified M13 helper phage (Phaberge) 
that has an amber mutation in its pIII genomic sequence and preferentially assembles using the pIII‑fusion protein. 
Also, both Cry1Ac and Cyt1Aa were efficiently displayed on ribosomes, which could allow the construction of large 
libraries of variants. Furthermore, Cry1Ac or Cyt1Aa displayed on M13 phages or ribosomes were specifically selected 
from a mixture of both toxins depending on which antigen was immobilized for binding selection. These improved 
systems may allow the selection of Cry toxin variants with improved insecticidal activities that could counter insect 
resistances.
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Introduction
Bacillus thuringiensis (Bt) produces insecticidal Cry pro-
teins that kill important crop pests and also mosquitoes 
that are vectors of human diseases (Bravo et  al. 2011; 
Pardo-López et  al. 2013). Bt strains produce different 
non-related Cry toxins including the 3-domain family of 
Cry toxins (3D-Cry) such as Cry1Ac or the Cyt family of 
toxins such as Cyt1Aa. Members of the 3D-Cry family 
show insect specificity to dipteran (ex. Cry4Ba), coleop-
teran (ex. Cry3Aa) and lepidopteran (ex. Cry1Ac) insects. 
It is widely accepted that 3D-Cry toxins exert their toxic 
effect by the sequential binding to insect gut proteins 
named cadherins and glycosyl-phosphatidyl-inositol 
(GPI) anchored proteins such as aminopeptidase-N 
(APN) or alkaline phosphatase (ALP) resulting in toxin 
oligomerization and pore formation that finally cause cell 
lysis and disruption of the insect gut (Pardo-López et al. 
2013).
Most Bt strains that show toxicity against dipteran 
insects also produce a different family of insecticidal 
proteins called Cyt toxins (Soberón et  al. 2013). Both 
Cry and Cyt toxins are synthesized as protoxins that are 
activated by insect gut proteases releasing active toxin 
fragments (Pardo-López et al. 2013). Cyt toxins are also 
pore-forming toxins, that in contrast to Cry toxins, does 
not interact with protein receptors binding directly to 
membrane lipids present in insect gut cells, resulting in 
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membrane insertion (Soberón et  al. 2013). More inter-
estingly, Cyt1Aa synergizes the insecticidal activity of 
the 3D-Cry Cry11Aa and Cry4Ba toxins by their binding 
interaction, functioning as a surrogate receptor molecule 
(Pérez et  al. 2005; Cantón et  al. 2011). Recently it was 
shown that Cyt2Aa specificity could be modified to kill 
aphids by the insertion of a peptide sequence, in exposed 
loop regions, that mediates binding to an aphid APN 
(Chougule et al. 2012).
The molecular evolution of Bt toxins could provide 
improved toxins against insect species that are poorly 
controlled by the available Cry toxins and also for the 
selection of Bt toxins that could recover toxicity to 
insects that develop resistance to the action of these pro-
teins (Bravo et  al. 2013). Different display systems that 
allow construction of libraries of mutants and selection 
of binders with improved affinity, along with the gene 
coding for these variants, have been developed such as 
phage display or ribosome display systems (Hanes and 
Plückthun 1997; Bratkovic 2010).
Phage display system allows selection of protein vari-
ants with improved binding characteristics (Azzazy and 
Highsmith 2002; Mullen et  al. 2006). For this purpose, 
the foreign protein DNA sequence is fused to a coat pro-
tein gene enabling the fusion protein to be displayed on 
the surface of the phage that can be then screened by 
enabling the phage to interact with ligands, a process 
known as biopanning allowing the molecular evolu-
tion of proteins (Dröge et  al. 2003; Mullen et  al. 2006). 
To display the fusion protein, it has to be translocated to 
the host periplasm by a peptide leader sequence while a 
helper phage provides all the necessary components for 
phage assembly. In contrast, the ribosome display system 
involves an in  vitro translation of the protein that pre-
vents the synthesized protein and the mRNA from leav-
ing the ribosome and binders with improved affinities are 
selected by panning (Hanes and Plückthun 1997). Ribo-
some-display allows construction of libraries with sizes 
up to 1014 in contrast with phage display where libraries 
of 109 size are typically obtained due to the limitation in 
E. coli transformation efficiency (Dreier and Pluckthun 
2011).
Cry1A toxins have been displayed in three different 
phages (M13, T7 and λ), these systems have shown dif-
ferent problems for displaying Cry toxins (Marzari et al. 
1997; Kasman et  al. 1998; Vílchez et  al. 2004; Pacheco 
et  al. 2006). In the case M13, the Cry1Aa and Cry1Ac 
toxins were not properly displayed resulting in deletions 
of the Cry1Aa-fused protein, while the displayed Cry1Ac 
protein did not bind to functional receptors in  vitro 
suggesting structural constraints of the toxin (Marzari 
et al. 1997; Kasman et al. 1998). In contrast the Cry1Ac 
toxin was efficiently displayed in both T7 and λ phages 
where the assembling of these phage particles occurs in 
the cytoplasm (Vílchez et al. 2004; Pacheco et al. 2006). 
Nevertheless, T7 and λ systems rely on in vitro packaging 
systems that are quite labile and have limitations for the 
construction of libraries with large number of variants 
with a limit up to 107 to 108 variants.
Improvement of M13 display can be achieved by using 
engineered helper phages such as the “Phaberge” helper 
phage that contains an amber mutation on its genome 
favoring the assembling of phage particles containing 
the recombinant pIII-fusion protein when non-suppres-
sive E. coli host cells were infected (Soltes et  al. 2003). 
Also, improvement of display of several different pro-
teins on M13 was achieved by changing the commonly 
used peptide leader sequence of the fusion protein, 
that relies on the Sec translocation pathway, for a pep-
tide leader sequence that relies on the signal recogni-
tion particle pathway (SRP) (Steiner et al. 2006). The Sec 
and SPR pathways translocate proteins to the periplasm 
post-translationally and co-translationally, respectively 
(Steiner et al. 2006). Contrary to phage display, ribosome 
display is a free-cell system that does not require in vivo 
processes to display the proteins; therefore the environ-
ment for production, folding and stability of the inter-
est-protein can be manipulated and optimized in  vitro. 
These features have been exploited to select and evolve 
peptides, proteins and antibody fragments (Wörn and 
Plückthun 2001; Jermetus et al. 2001; Osada et al. 2009; 
Mouratou et al. 2007; Correa et al. 2014).
In this work, we have adapted and/or improved these 
two complementary systems with the aim to maximize 
chances to have an efficient display whatever the family 
of Cry toxins to evolve. We show the successful display 
of Cry1Ac and Cyt1Aa toxins on M13. Also, Cry1Ac 
and Cyt1Aa were successfully displayed using ribosome-
display. The two Bt toxins retain their specific binding 
characteristics for their specific ligands. Furthermore, 
we show that specific selection of the displayed toxins 
by biopanning. These improved systems may allow the 
selection of Cry toxin variants with improved insecticidal 
activity that could counter insect resistances.
Materials and methods
Molecular biology
Enzymes, buffers and mass weight marker were from 
Fermentas, Thermo Scientific. All PCRs were performed 
with Phusion DNA-polymerase with HF buffer. Primers 
sequences are provided at Table 1.
Preparation of Bt toxins and cadherin fragment CR7‑12
Crystals of Cry1Ac, Cry11Aa, Cry3Aa and Cyt1Aa were 
produced from Bacillus thuringiensis, purified, solubi-
lized and activated as previously reported (Gómez et al. 
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2001; Pérez et al. 2005). Cadherin fragment CR7-12 was 
expressed in E. coli ER2566 and purified with nickel affin-
ity column as reported (Pacheco et al. 2009).
Phagemids construct and cloning
The signal sequence PelB of the pCANTAB 5E phagemid 
was substituted by ssDsbA to construct pCAD phagemid. 
The ssDsbA was synthetized by overlapping-PCR of 
four primers as previously reported (Steiner et al. 2006). 
Briefly, 10 pmol of SP1 and SP2 primers were mixed and 
assembled at 72  °C for 10  min with Phusion DNA-pol-
ymerase, then 1 μl of the assembly reaction was used as 
template and amplified with SPIII and SP4 primers. The 
PCR product was separated by agarose-gel electrophore-
sis and ligated into pCANTAB 5E after restriction with 
HindIII and SfiI enzymes. Phagemid pCADS was con-
structed by mutagenizing the TAG amber stop codon of 
pCAD phagemid by CAG codon with the primer SupASC 
using the QuikChange II Site-Directed Mutagenesis Kit 
(Agilent Technologies) following the manual instruc-
tions. The cry1Ac toxic fragment coding-sequence (G26-
A614) (GenBank No. AM949588) was amplified by PCR 
from Bacillus thuringiensis strain HD73 (Bacillus Genetic 
Stock Center-BGSC- No. 4D4) using the primers FFTc-
M13/RFTc-M13. The cyt1Aa protoxin fragment coding-
sequence (GenBank No. X03182) was amplified by PCR 
from pWF45 vector (Wu and Federici, 1993) using the 
primers Pro-SfiI/Pro-NotI. The cry3Aa toxic fragment 
coding-sequence (K63-N644) (GenBank No. AJ237900) 
was amplified by PCR from Bacillus thuringiensis 
subsp. tenebrionis (BGSC No. 4AA1) using the prim-
ers 3Aup/3Alow. All the PCR-amplified toxin fragments 
were ligated after digestion with SfiI and NotI restriction 
enzymes on previously digested pCANTAB 5E, pCAD or 
pCADS phagemids.
Phage production and purification
The pCANTAB 5E and pCADS phagemids with the 
cry1Ac toxin gene inserted were transformed into E. coli 
XL1-Blue MRF’, while pCADS with cry1Ac and cyt1Aa 
toxin genes were transformed into E. coli HB2151. A sin-
gle colony was grown overnight at 37 °C in 3 ml of 2xYT 
medium containing 100 μg/ml ampicillin. The overnight 
culture was used to inoculate 35 ml of 2xYT containing 
100  μg/ml ampicillin and were incubated at 37  °C until 
reaching an OD600 of 0.6. The E. coli XL1-Blue MRF’ or 
HB2151 cultures were infected with 1011 particles of 
helper phages VCSM13 or Phaberge (which was kindly 
donated by Dr. Erik J. Wiersma), respectively. After 
30  min of incubation at room temperature, kanamycin 
(30  μg/ml) was added and the cultures were incubated 
at 30  °C overnight. The supernatants were separated by 
centrifugation and 6 ml of PEG-NaCl solution (20 % PEG 
8000/2.5  M NaCl) was added and incubated at 4  °C for 
Table 1 List of primers
Sequences of the restriction sites are underlined
Primer Sequence (5′→3′) Restriction site
SP1 AGAGCATGCGTAGGAGAAAATAAAATGAAAAAGATTTGGCTGGCGCTGGCTGG –
SP2 TCTTTGTAGTCCGCCGATGCGCTAAACGCTAAAACTAAACCAGCCAGCGCCAGCC –
SP3 CCCCAAGCTTGGGAGAGCATGCGTAGGAG Hind III
SP4 (GA)10GGCCGGCTGGGCCCCTTTGTAGTCCGCCG Sfi I
SupASC GGAACCGCGTGCCGCACAGACTGTTGAAAGTTG –
FFTcM13 (GA)10GGCCCAGCCGGCCGGAGAAAGAATAGAAACTGG Sfi I
RFTcM13 ATAGTTTAGCGGCCGCTGGAATAAATTCAAATCTGTC Not I
FDIIc TCACGGATCCAGAGAAATTTATACAAACCCAGTATTAGAAAAT Bam HI
RDIIc TATAAAGCTTACTACGATGTATCCAAGAGAACATAGGAGCTCTTATTATACT Hind III
3Aup (GA)10GGCCCAGCCGGCCAAAGATGTCATTCAAAAAGGC Sfi I
3Alow (GA)10GCGGCCGCATTCACTGGAATAAATTCAATTTTGTC Not I
Pro‑Sf1 (GA)10GGCCCAGCCGGCCATGGAAAATTTAAATCATTGTCC Sfi I




FFTc TCACGGATCCGGAGAAAGAATAGAAACTGG Bam HI
RFTc TATAAAGCTTTGGAATAAATTCAAATCTGTC Hind III
CytFRD CACGGATCCCCAAATGAAATCAATAATCTTC Bam HI
CytRRD ATAAAGCTTTGGTTGTGCAAATTTCAAAGATTG Hind III
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1  h. The phages were precipitated by centrifugation at 
8500g for 10 min at 4 °C and the pellet was suspended in 
1 ml of PBS pH 7.4. Finally the phage titer was estimated 
counting colonies resistant to ampicillin after E. coli XL1-
Blue MRF’ infection.
Phage blot
1011 phage particles were mixed in Laemmli buffer and 
boiled for 5  min. The mixture was separated by SDS-
PAGE and then electrotranferred to PVDF Immobilon-P 
membrane (Millipore). After blocking with PBS-M (PBS, 
5 % skim milk) for 1 h, the membrane was incubated with 
polyclonal rabbit antibodies anti-Cry1Ac or anti-Cyt1Aa 
(1:20,000 in PBS, 0.1  % Tween-20). The membrane was 
incubated for 1 h with the secondary antibody anti-rabbit 
IgG-HRP (Santa Cruz Biotechnology) diluted to 1:30,000 
in PBS-T. Finally, blots were visualized with Western 
Blotting Luminol Reagent (Santa Cruz Biotechnology) 
and densitometry was performed with ImageJ software 
(http://imagej.nih.gov/ij/).
Phage binding
ELISA 96-well microplates were coated overnight at 4 °C 
with 100 µl of either cadherin protein fragment CR7-12 
(200 nM), anti-Cry1Ac antibody (1:1000) or anti-Cyt1Aa 
antibody (1:1000) diluted in PBS. The plates were blocked 
with 200 µl/well of PBS-M for 1 h at 37 °C. Phages parti-
cles (1010) per well diluted in PBS-T were added and incu-
bated for 1 h, then the unbound phages were removed by 
washing with PBS-T. The anti-pVIII-HRP secondary anti-
body (1:5000) was added and incubated for 1 h. The HRP 
enzymatic activity was revealed with 100 µl of substrate 
solution (1 mg/ml ortho-phenylenediamine, 0.05 % H2O2, 
100 mM NaH2PO4 pH 5.0). Reaction was stopped adding 
50 µl of 1 M H2SO4 and measured at 490 nm using the 
Emax Precision Microplate Reader, Molecular Devices.
For competition binding assay, M13-Cry1Ac phages 
were incubated in presence of increasing concentrations 
of soluble Cry1Ac toxin and the phage binding was per-
formed as described above.
Insect bioassay
Manduca sexta neonate larvae were reared on an artificial 
diet in 24-well plates. Cry1Ac activated toxins (10 ng/cm2), 
M13-Cry1Ac or M13 wild-type phages (1011 pfu/cm2) 
were applied on the surface of diet and one neonate larvae 
was placed per well. Mortality was recorded after 7  days 
at 28 °C, 65 ± 5 % relative humidity and a photoperiod of 
16/8 h light/dark. Mortality was scored after 7 days.
Phage selection
ELISA 96-wells plates were coated with the bait antigen 
(CR7-12, anti-Cry1Ac or anti-Cyt1Aa) as described for 
phage binding. A mixture 1:1 of M13-Cry1Ac or M13-
Cyt1Aa (1010 pfu/100  μl) in PBS-T was added per well 
and incubated for 1  h at room temperature with gentle 
shaking. The wells were washed ten times with PBS-T 
and 100  μl of E. coli XL1-Blue MRF’ grown in 2xYT 
medium until OD600 0.6 were added. The plates were 
incubated for 30  min at room temperature to allow the 
infection and the cells were collected and diluted in 
1.4  ml of a 2xYT medium. An aliquot of 50  μl of cells 
diluted were plated on agar LB plates containing ampi-
cillin 100  μg/ml and were incubated at 37  °C for 16  h. 
To determine which phages were selected depending on 
bait was used as antigen, colony-PCR was performed to 
identify the phagemid by amplifying either the cry1Ac or 
cyt1Aa genes with the primers FFTc-M13/RFTc-M13 or 
Pro-SfiI/Pro-NotI, respectively. The PCR-products were 
evaluated by agarose gel electrophoresis.
In vitro transcription and translation
To prepare the mRNA of Cry1Ac (G26-P607), domain II of 
Cry1Ac (Q262-S459) or Cyt1Aa (P34-P229), the gene frag-
ments were PCR amplified with primers FFTc/RFTc, FDIIc/
RDIIc or CytF-RD/CytR-RD, respectively. After restric-
tion with BamHI and HindIII enzymes, the PCR fragments 
were inserted into pFPRDV plasmid. To obtain the DNA 
template for in vitro transcription, the outer primers T7B 
and TolAkurtz were used to introduce, by PCR amplifica-
tion, T7 promoter, ribosome binding site and TolA spacer 
sequences. The PCR products were used as DNA template 
for in vitro transcription using TranscriptAid T7 High Yield 
Transcription Kit (Fermentas, Thermo Scientific).
For in  vitro translation, S30 extract were prepared 
as described previously (Dreier and Pluckthun 2011). 
Briefly, E. coli MRE600 were grown in rich medium 
(40 mM KH2PO4, 165 mM K2HPO4, 10 g/L yeast extract, 
15  μg/ml thiamine, 2  % glucose, 1  mM MgOAc) until 
DO600 of 1.0. Cells were washed three times with buffer 
S30 (14  mM MgOAc, 60  mM KOAc, 10  mM Tris-OAc 
pH 7.5) and lysed with French press. Afterward, the lysate 
was clarified by centrifugation at 30,000 g and then it was 
dialyzed overnight with buffer S30. The ternary complex 
was prepared in a translation reaction of 27.5 μl contain-
ing 2.5 μg of mRNA, 12.5 μl of S30 extract and 11 μl of 
PremixZ (Dreier and Pluckthun 2011). The reaction was 
incubated at 37 °C for 15 min and then was placed on ice. 
To maintain the ternary complex, 75 μl of WB (50 mM 
Tris–Acetate pH 7.5, 150 mM NaCl, 50 mM Magnesium 
Acetate) were added; to dissociate the ternary complex, 
75 μl of TBS were added.
ELISA test of the in vitro translated toxins
ELISA microplates coated with the bait antigen were 
blocked with TBS-BSA 0.5  %. An in  vitro translation 
Page 5 of 10Pacheco et al. AMB Expr  (2015) 5:73 
reaction prepared with cry1Ac or cyt1Aa mRNA and 
stopped with TBS, was applied and incubated for 1 h with 
gentle shaking at room temperature. Binding of Cry1Ac 
against cadherin fragment CR7-12 was detected with the 
polyclonal antibody anti-Cry1Ac followed of secondary 
antibody anti-rabbit IgG-HRP. In the case of immobi-
lized antibodies anti-Cry1Ac or anti-Cyt1Aa the binding 
was detected with an antibody anti-RGS-His-HRP. HRP 
enzymatic activity was revealed as was described above.
Recovery of RNA after binding selection of ternary 
complexes
ELISA microplates coated with the bait antigen (CR7-12, 
Cry11Aa or anti-Cyt1Aa) were blocked with TBS-BSA 
0.5 % and washed with WB. An in vitro translation reaction 
prepared with an equimolar mixture of Cry1Ac and Cyt1Aa 
mRNA and stopped with WB, was applied and the plate was 
incubated 1 h with gentle shaking at 4  °C followed by ten 
washes steps with WB-T. The mRNA was eluted with 100 µl 
of elution buffer (50 mM Tris-HOAc pH 7.5, 150 mM NaCl, 
10 mM EDTA, 5 µg Saccharomyces cerevisiae RNA) during 
10 min at 4 °C with gentle shaking and purified with RNe-
asy kit (Qiagen). Reverse transcription was performed with 
RevertAid RT Kit (Fermentas, Thermo Scientific) according 
to manual instructions. The cDNA obtained from reverse 
transcription with the reverse primers RFTc or CytR-RD 
was PCR-amplified with the primers SD-MRGS/RFTc or 
SD-MRGS/CytR-RD, respectively. Finally, the PCR products 
were analyzed by agarose gel electrophoresis.
Results
Constructs for the display of Bt toxins on phages
With the aim to improve the phage display of Bt toxins 
we compare the display efficiency of Bt toxins on M13 
phage by using the secretory Sec or SRP pathways. We 
designed a phagemid for the fusion of Bt toxins to pIII 
viral protein that depends on a SRP signal sequence. The 
ssDsbA, which tags the proteins to its SRP-dependent 
translocation, was generated by assembly-PCR as pre-
viously reported (Steiner et  al. 2006). The pCANTAB 
5E phagemid was used as backbone vector (Amersham 
Biosciences) and the ssPelB was substituted by ssDsbA, 
hereafter called pCAD (Fig. 1a). In addition, to increase 
the display levels of toxin by using a helper phage with 
a conditional deficiency of pIII production (phaberge), 
the amber stop codon of pCAD between the toxin-pIII 
fusion was mutagenized (pCADS vector).
SRP pathway increases the display level of functional Bt 
toxins
The display efficiency by Sec and SPR translocation of the 
toxic fragment of Cry1Ac toxin (G26-A614) were com-
pared. M13 phages were prepared from E. coli cells har-
boring pCANTAB 5E-Cry1Ac or pCAD-Cry1Ac vectors. 
The same amount of phage particles (1011) were subject 
to SDS-PAGE and the fusion protein Cry1Ac-pIII was 
revealed by western blot with anti-Cry1Ac polyclonal 
antibody. Figure  2a shows that the M13 phages pre-
pared with pCAD produced two fold more of the fusion 
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Fig. 1 a Schematic representation of the phagemid constructs for phage display. ASC amber stop codon. b Schematic representation of the con‑
structs for ribosome display. RBS, ribosome binding‑site. Horizontal arrows indicate the annealing region of the primers at the constructs
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Cry1Ac-pIII protein than M13 phages prepared from 
pCANTAB 5E as judged by scanning the optical density 
of the 100 kDa band.
The binding of Cry1Ac-M13 phages to cadherin frag-
ment from domain repeats CR7 to CR12 of M. sexta 
(M810-A1485), which is a functional receptor for Cry1Ac 
(Pacheco et al. 2009), was analyzed. Figure 2b shows an 
ELISA binding assay showing that M13-Cry1Ac prepared 
from E. coli cells harboring the phagemid pCAD-Cry1Ac 
bound to CR7-12. An ELISA competitive assay showed 
that the binding of virions M13-Cry1Ac to CR7-12 was 
specific since it was competed by Cry1Ac toxin (Fig. 2c). 
The toxicity of the virions Cry1Ac-M13 was analyzed in 
bioassays by diet surface exposure showing that Cry1Ac-
M13 was toxic to M. sexta larvae indicating that the 
display toxin retains its insecticidal activity (Fig.  2d). 
Together these results show that the display Cry1Ac 
toxin using the ssDsbA retains its receptor binding and 
toxicity features suggesting no structural constrains in 
the toxin displayed.
It is well established that pIII-deficient helper phages 
increase the amount of exogenous protein displayed on 
M13 (Soltes et al. 2003). Phaberge is a helper phage with 
an amber stop codon in pIII gene, therefore non-SupE 
E. coli strains reduce the amount of non-fused pIII pro-
duction and most is provided for phage assembly by the 
phagemid containing the pIII fused protein. To test if 
Phaberge increases the level of Cry1Ac-pIII incorporated 
to the capsid, we used the non-SupE E. coli HB2151 strain 
housing the pCADS-Cry1Ac vector and M13 phage 
were produced. Western-blot analysis of the viral parti-
cles showed more than two fold increased production of 
Cry1Ac-pIII protein compared with the same construct 
using M13 phage (Fig. 2a, lanes 3 and 4).
In order to test if Cyt1Aa toxin can be displayed on 
M13 phage, we cloned Cyt1Aa protoxin fragment in 
pCADS vector. Phages prepared with this construct were 
analyzed as was described for M13-Cry1Ac. Figure  3a 
shows a phage blot assay showing that Cyt1Aa protoxin 
is displayed on filamentous phages. Figure  3b shows 
that the phages M13-Cyt1Aa are able to bind to Cyt1Aa 
antibody.
Ribosome display of Bt toxins
In contrast to phage display, ribosome display is a fully 
in  vitro method for molecular display. To explore the 
ribosome display as alternative display system, Bt tox-
ins genes were cloned in the pFPRDV vector (Correa 
et al. 2014). This vector enables the incorporation of T7 
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Fig. 2 a Western blot analysis of 1011 M13 phages displaying Cry1Ac toxin prepared from E. coli cells harbouring the phagemids pCANTAB 
5E‑Cry1Ac (lane 2), pCAD‑Cry1Ac (lane 3) or pCADS‑Cry1Ac (lane 4). Lane 1 is trypsin‑activated Cry1Ac toxin and lane 5 is the M13 helper phage. 
Values above the bands indicate the number fold of Cry1Ac displaying level as judged by the optical density of the 100 kDa band. b ELISA binding 
assays of M13‑Cry1Ac phage particles, prepared from the phagemid pCAD‑Cry1Ac, to cadherin fragment CR7‑12. c Analysis of binding competition 
by ELISA of M13‑Cry1Ac in presence of increasing concentrations of Cry1Ac toxin. d Toxicity of Cry1Ac‑M13 (1011) to neonates M. sexta larvae after 





















Fig. 3 a Western blot analysis of M13 phage particles displaying 
Cyt1Aa toxin prepared from E. coli cells harbouring the phagemid 
pCADS‑Cyt1Aa. Lane 1 Cyt1Aa protoxin; lane 2 M13‑Cyt1Aa phage 
particles; lane 3, M13 helper phage. b ELISA binding assay of M13‑
Cyt1Aa to immobilized polyclonal anti‑Cyt1Aa antibody. Error bars 
represent the standard deviation
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promoter and ribosome binding-site sequences for tran-
scription and translation in  vitro, respectively; also the 
fusion of TolA spacer at C-terminal of the toxins without 
stop-codon is included in pFPRDV (Fig.  1b). The toxic 
fragments of Cry1Ac or Cyt1Aa toxins were PCR ampli-
fied from the constructs of pFPRDV using the prim-
ers T7B and TolAkurtz as described in materials and 
methods (Fig.  4a). The PCR product contains all neces-
sary elements for ribosome display: the T7 promoter for 
in vitro transcription with T7 polymerase, the canonical 
Shine-Delgarno ribosome binding-site sequence for an 
efficient translation with S30 extract prepared from E. 
coli and the toxin-coding sequence fused to TolA spacer, 
which remains anchored into the ribosomal tunnel at the 
ternary complex. The fragments obtained by PCR were 
in  vitro transcribed and analyzed by agarose gel elec-
trophoresis. Figure 4b shows the mRNA bands with the 
expected molecular weight of approximately 1850 bp for 
cry1Ac or 650 bp for cyt1Aa.
Since ribosome display is an in vitro system, one of the 
challenges is to prevent the misfolding of the nascent 
protein, in particular those with disulfide bridges. It has 
been established that S30 extract from E. coli contains 
accessory protein, such as chaperones, that enable the 
correct folding and stability of displayed proteins during 
in vitro translation (Wörn and Plückthun 2001; Jermetus 
et al. 2001). The advantage to display Bt toxins in a toxic 
fragment format is the lack of disulfide bridges since 
cysteins residues are removed after toxin activation. To 
determine that Cry1Ac toxin is folded correctly we ana-
lyzed the binding ability of ternary complex to the recep-
tor CR7-12 by ELISA binding assays. Figure  4c shows 
that ternary complex prepared with Cry1Ac mRNA spe-
cifically bound to CR7-12. Polyclonal antibodies anti-
Cry1Ac and anti-Cyt1Aa or Cry11Aa toxin immobilized 
on ELISA-wells were also able to trap the ternary com-
plex prepared with mRNA of Cry1Ac or Cyt1Aa toxins, 
respectively (Fig. 4c).
Specific selection of Bt toxins by phage display 
and ribosome display
The success of molecular display techniques relies on 
a physic link between the protein displayed (pheno-
type) and the coding-sequence (genotype). We showed 
the functional display of Bt toxins on M13 phages and 
ribosomes. To determine that we are able to recover 
the genetic information, input M13 phages display-
ing Cry1Ac or Cyt1Aa toxins were mixed 1:1 ration and 
selected against cadherin fragment CR7-12, anti-Cry1Ac 
antibody or anti-Cyt1Aa antibody. After selection, E. coli 
was infected with the output phages and ten clones were 
randomly selected to identify the cry1Ac or cyt1Aa genes 
from the phagemids by PCR amplification. Figure  5a 
shows that the ten clones analyzed presented a DNA 
fragment of 1.8 kb that corresponds to cry1Ac gene when 
the mixture of phages were selected against cadherin 
fragment CR7-12 or anti-Cry1Ac antibody. In the case 
where anti-Cyt1Aa antibody was used as bait, nine clones 
contained the fragment of 0.65  kb that corresponds to 
cyt1Aa gene. These data shows that we can recover spe-
cifically the Bt toxin gene with its cognate ligand used as 
bait for biopanning.
In the case of the toxins displayed on ribosomes, we 
carried out a similar scheme of selection with ternary 
complex prepared with 1:1 equimolar ration of Cry1Ac 
and Cyt1Aa mRNA. After affinity selection, the mRNA 
was eluted, reverse transcribed and the cDNA was used 
as template in a PCR reaction to amplify the cry1Ac or 
cyt1Aa gene. As was expected, mRNA of Cry1Ac toxin 













































Fig. 4 a DNA template prepared by PCR amplification for ribosome display of Cry1Ac and Cyt1Aa toxins. MWM Mass weight marker GeneRuler 1 kb 
DNA Ladder. b mRNA of Cry1Ac and Cyt1Aa obtained from in vitro transcription. MWM, Mass weight marker RiboRuler 6000 RNA Ladder c ELISA 
binding assay of the nascent Cry1Ac or Cyt1Aa toxin from ribosomal complex
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cadherin fragment CR7-12 or antibody anti-Cry1Ac were 
used as bait. In the case of the mRNA of Cyt1Aa toxin 
was only recovered when the bait was the antibody anti-
Cyt1Aa antibody or Cry11Aa toxin (Fig. 5b).
Discussion
Although display in phages of Cry toxins has shown not 
to be optimal (Bravo et  al. 2013), few examples of suc-
cessful selection of improved variants of certain Cry tox-
ins have been reported (Ishikawa et  al. 2007; Craveiro 
et al. 2010; Oliveira et al. 2011). Nevertheless the display 
systems used are not likely to be efficient to display and 
select improved variants for most Cry toxins (Ishikawa 
et  al. 2007; Craveiro et  al. 2010; Oliveira et  al. 2011). 
Therefore, the improvement of display systems that effi-
ciently display Cry toxins allowing the creation of large 
libraries could provide means for rapid evolution of most 
Bt toxins.
In the case of phage display we show here that the dis-
play of two structurally non-related Bt toxins could be 
improved by changing the peptide leader sequence of 
the fusion protein, that relies on the Sec translocation 
pathway, for a peptide leader sequence that relies on the 
signal recognition particle pathway (SRP). Since the Sec 
pathway translocates proteins post-translationally while 
the SRP pathway co-translationally, this result suggests 
that Cry1Ac folding in the cytoplasm limits transloca-
tion and display efficiencies. Furthermore, we show that 
by using a helper phage (Phaberge) that assembles phage 
particle preferring the Cry1Ac-pIII fusion protein, dis-
play of Cry1Ac was further improved (Fig.  1a). More 
interestingly we show that Cry1Ac is properly folded 
retaining its receptor binding capacities and toxicity. 
Using the system described here we have successfully dis-
played Cry3Aa toxin that is toxic to coleopteran insects 
(Additional file  1: Figure S1). The phage display system 
described here allows great flexibility for panning selec-
tion since the different display levels of Cry toxins could 
be used for selection of variants with different binding 
affinities. Enhanced display of Bt toxin libraries using 
Phaberge and SRP translocation sequence are likely to 
select binders with moderate affinity due to the selection 
of binders by avidity since several binding sites are pre-
sent in one phage particle. Consecutive mutagenesis and 
selection using display systems that allow moderate (SRP 
sequence and M13) or low (Sec sequence and M13) dis-
play efficiencies would select binders with higher binding 
affinities. We believe that depending on the binding tar-
get (receptor vs insect gut membranes) and toxicity of the 
native Cry toxin used for library construction the phage 
display systems described here could be useful to put in 
place a panning procedures to select improved toxins.
Ribosome display has the unique feature that it allows 
the construction of large libraries that are more likely to 
be useful to select toxins with improved binding and tox-
icity. We show here that Cry1Ac toxin of 60 kDa is effi-
ciently displayed in ribosomes and that selection with a 
cadherin receptor specifically selected Cry1Ac-displayed 
ribosomes. To our knowledge this is the first example of 
a protein of more than 50  kDa that is successfully dis-
played in ribosomes. It still needs to be determined if 
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Fig. 5 a Colony PCR after affinity selection of M13‑toxins phage particles. A mixture of M13‑Cry1Ac and M13‑Cyt1Aa phages (1:1) was applied to 
immobilized cadherin fragment CR7‑12 (1), anti‑Cry1Ac antibody (2) and anti‑Cyt1Aa antibody (3). E. coli XL1‑Blue MRF’ cells were infected with the 
output phages and ten random colonies were analyzed by PCR to amplify cry1Ac or cyt1Aa. b RT‑PCR products after selection of ternary complex 
prepared with a mixture of Cry1Ac and Cyt1Aa mRNA (1:1) against cadherin fragment CR7‑12, anti‑Cry1Ac antibody, anti‑Cyt1Aa antibody or 
Cry11Aa toxin. Lane 1 RT‑PCR preformed with specific primers for Cry1Ac toxin; lane 2 RT‑PCR performed with specific primers for Cyt1Aa toxin. 
MWM Mass weight marker GeneRuler 1 kb DNA Ladder
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on ribosomes to determine if ribosome-display could be 
a general system for evolution of other 3D-Cry toxins. 
However, it is still possible to display individual domains 
II or III that are involved in receptor binding for library 
construction and selection of improved binders using 
ribosome display. In this regard, we have successfully dis-
played Cry1Ac domain II and shown that it retains cad-
herin receptor binding (Additional file 1: Figure S2).
In the case of Cyt1Aa we show that is can be efficiently 
displayed using both the improved phage display system 
described here and also using ribosome display. Neverthe-
less, Cyt1Aa was capable of Cry11Aa binding only when 
displayed in ribosomes (Fig.  5b) in contrast when dis-
played in M13 where it was not capable to bind Cry11Aa 
(data not shown). As mentioned earlier, Cyt1Aa enhances 
the toxicity of Cry11Aa or Cry4Ba against mosquitoes by 
functioning as a surrogate receptor. We will use ribosome 
display to select Cyt1Aa mutants that bind other Cry tox-
ins as a way to develop tools for improving Bt Cry toxic-
ity against specific insect targets. In the case of Cyt2Aa 
toxin it was shown that insertion of a peptide sequence 
with aphid APN binding activity in certain loop regions 
resulted in Cyt2Aa toxins with aphid toxicity (Chougule 
et al. 2012). Thus, by using both display systems described 
here, selection of Cyt1Aa variants capable to bind to 
insect gut membranes of certain insect species could 
select Cyt1Aa toxins with toxicity to certain insect pests.
Overall we describe here two efficient display systems 
for Bt toxins that are likely to be useful to evolve Bt toxic-
ity to control pets that show low susceptibility to these 
toxins or to control insect pests that evolved resistance to 
Cry toxins in field conditions.
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